Aim To analyse ab interno trabeculectomy (AIT) with the trabectome and combined phacoemulsification with AIT (phaco-AIT) by Shaffer angle grade (SG).
Methods Prospective study of AIT and phaco-AIT with narrow angles of SG≤2 versus open angles ≥3. Outcomes included intraocular pressure (IOP), medications, complications, secondary surgery and success (IOP <21 mm Hg and >20% reduction without further surgery). Exclusion criteria were missing preoperative data and <1 year follow-up.
Results Of 671 included cases, at 1 year AIT SG≤2 (n=43) had an IOP reduction of 42% from 27.3±7.4 to 15.7±3.0 mm Hg (p<0.01) versus AIT SG≥3 (n=271) with an IOP reduction of 37% from 26.1±7.8 to 16.4±3.9 mm Hg (p<0.01). In phaco-AIT with SG≤2 (n=48), IOP was reduced 24% from 20.7±7.0 to 15.7±3.6 mm Hg (p<0.01) versus phaco-AIT with SG≥3 (n=309) with an IOP reduction of 25% from 22.6±6.4 to 17.0±3.4 mm Hg (p<0.01). There was no difference between SG≤2 and SG≥3 in reduction of IOP or medications, complications, secondary surgery and success rates (p>0.05).
Conclusions SG≤2 is not associated with worse outcomes in AIT or phaco-AIT.
- Treatment Surgery
- Anterior chamber
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Ab interno trabeculectomy (AIT) with the trabectome (Neomedix Corporation, Tustin, California, USA) is a nearly 10-year old,1 minimally invasive glaucoma surgery (MIGS) modality that lowers the intraocular pressure (IOP) by increasing aqueous outflow using plasma-mediated ablation of trabecular meshwork (TM).2 A narrow anterior chamber angle is considered a relative contraindication because surgeons feel that, in addition to an often less direct access during surgery, peripheral anterior synechiae, descemetisation of the angle and fibrosis may form more readily and hasten failure.3 This may preclude a large numbers of glaucoma patients from AIT and similar MIGS which have a highly favourable risk profile compared with traditional filtering glaucoma surgery with near absence of vision-threatening complications: while 74% of glaucomas present with an open angle, angle-closure glaucoma contributes up to 70% of glaucoma cases in women and to 87% of cases in Asians.4 Progressively narrow angles have been shown to be correlated with higher IOP, presumably by causing higher outflow resistance.5 Conversely, cataract surgery alone has been shown to deepen the angle and lower IOP.6
Although numerous studies have described the safety and efficacy of AIT in the treatment of glaucoma,1 ,7 the relationship between anterior chamber angle grade and outcomes has not been formally examined. The purpose of this nonrandomised study was to gain insight into whether the degree of preoperative angle opening relates to IOP outcomes of AIT or combined phacoemulsification with AIT (phaco-AIT), respectively. We hypothesised that narrow angles would be associated with worse IOP reduction and a higher failure rate.
Subjects were enrolled from the Trabectome Study Group database,7 a postmarket surveillance requirement for Neomedix, and divided into phakic patients who had only trabectome-mediated AIT or combined phacoemulsification with AIT (phaco-AIT). Data for this study were collected with institutional review board approval, in accordance with the Declaration of Helsinki and the Health Insurance Portability and Accountability Act.
This prospective interventional cohort included all phakic patients with a diagnosis of glaucoma (with or without visually significant cataract), who had 12 months of follow-up. Anterior chamber angles in all patients were graded by Shaffer grade (SG),8 the most commonly used classification system in which ‘0’ to ‘slit’ represents a totally or partially closed angle with potential for angle closure that is present or very likely, ‘1’ an angle width of 10° (very narrow) and closure potential that is probable, ‘2’ representing 20° and possible potential for closure, ‘3’ standing for 20° to 45° with unlikely closure and grade ‘4’ indicating a wide open angle and improbable potential for angle closure. Subjects were excluded if they had missing preoperative IOP data or end-stage visual field (VF) damage.
The indication for AIT alone in phakic eyes consisted of IOP above target with progressive glaucoma on maximally tolerated medical or laser therapy. All surgeons were recommended to follow the standard postoperative protocol consisting of 1% pilocarpine four times per day for 1 month then three times per day for 1 month, 1% prednisolone acetate four times per day for 1 week to be tapered by one drop each week and a fourth or third generation fluoroquinolone four times per day for 1 week. Glaucoma medications could be continued as deemed necessary to achieve target pressures. Deviations from this protocol were allowed at the clinician's discretion and not monitored.
We converted visual acuities to logarithm of the minimum angle of resolution (logMAR). The indication for phaco-AIT consisted of a visually significant cataract with at least 0.4 logMAR (20/50 Snellen) visual brightness acuity testing and the need to lower IOP or the number of glaucoma medications. VF status was categorised as early, moderate or advanced by individual glaucoma specialists based on the most recent Humphrey VF exams (Carl Zeiss Meditec AG, Jena, Germany). All patients had a comprehensive slit lamp and ophthalmoscopy exam prior to surgery.
The major outcome measures included IOP, number of glaucoma medications, and need for secondary glaucoma surgery. Each hypotensive agent in an eye drop was counted as a glaucoma medication. Pilocarpine and oral carbonic anhydrase inhibitors were also counted as a glaucoma medication. We used the Wilcoxon test to compare IOP and number of medications within each group and between groups, and the Mann–Whitney test and χ2 test to compare continuous and categorical variables between groups, respectively. All statistical analyses were performed using R.9 Statistical significance was set at p<0.05. Continuous variables were expressed as mean±SD. We created scattergrams to illustrate individual outcomes and survival plots using a Kaplan–Meier survival analysis. Success was defined as a final IOP <21 mm Hg and a >20% reduction from baseline without further surgery. We analysed survival rates by SGs with the log-rank test.
After applying exclusion criteria, a total of 671 eyes from 671 patients were included in this study (figure 1). In AIT, there were eight patients in SG1, 35 in SG2, 118 in SG3 and 153 in SG4. In phaco-AIT, there were six patients in SG1, 42 in SG2, 146 in SG3 and 163 in SG4. All patients were phakic and underwent AIT alone or phaco-AIT and had at least 12 months of follow-up. Baseline patient demographics are presented in table 1. We estimated that the power to detect a difference of 3 mm Hg between groups was 97% given the unequal sample sizes and the observed SD.
In the baseline patient demographics (table 1), the phaco-AIT group was on average about a decade older than the AIT group and the SG≤2 subgroup was older than SG≥3. Visual acuity in phaco-AIT improved significantly after surgery. AIT SG≤2 had proportionally more African–Americans, fewer Asians, and more subjects with a cup-to-disc ratio above 0.8 compared with AIT SG≥3. Additionally, the severity of VF damage was associated with SG groups primarily due to the substantial amount of advanced VF damage in SG≥3 that matched the greater number of cases with a cup-to-disc ratio above 0.8.
Figures 2 and 3 show the preoperative and postoperative IOP measurements and change in glaucoma medications over time in AIT and phaco-AIT, respectively. In AIT SG≤2, the mean IOP was reduced from 27.3±7.4 to 15.7±3.0 mm Hg (42% decrease, p<0.01), on 0.2 fewer medications (p=1.00) at 12 months. In AIT SG≥3, the mean IOP was reduced from 26.1±7.8 to 16.4±3.9 mm Hg (37% decrease, p<0.01) on 0.8 fewer medications (p<0.01). In phaco-AIT SG≤2, the mean IOP was reduced from 20.7±7.0 to 15.7±3.6 mm Hg (24% decrease, p<0.01), on 0.8 fewer medications (p<0.01). In phaco-AIT SG≥3, the mean IOP was reduced from 22.6±6.4 to 17.0±3.4 mm Hg (25% decrease, p<0.01) on 0.7 fewer medications (p<0.01). Online supplementary table S1 details how many patients in each study group were using 0, 1, 2, 3 or 4 medications at each time point.
Table 2 indicates similar surgical success in AIT and phaco-AIT by SG using various criteria. The scattergrams in figure 4 plotted the 1 and 12 month IOP against the baseline IOPs of each group. A few higher IOPs were recorded in select individuals at 1 month compared with 12 months. No significant differences were found between any single group or between all AITs (SG≤2 plus SG≥3) compared with all phaco-AIT (SG≤2 plus SG≥3; p>0.05). Figure 5 shows comparable survival plots with no significant difference between SG≤2 and SG≥3 groups for neither AIT (p=0.70) nor phaco-AIT (p=0.56) although the survival curve for SG≥3 both AIT and phaco-AIT was slightly above those for SG≤2.
Table 3 presents postoperative complications. A total of 63 AIT and 11 phaco-AIT cases went on to require further glaucoma surgery within 12 months. There was no statistical difference in secondary surgery events when compared by SG. There were five cases of transient hypotony in both the AIT and phaco-AIT SG≥3 groups, but the hypotony spontaneously resolved and there was no vision loss. There were no serious complications that are commonly seen in trabeculectomy or tube shunt surgery including aqueous misdirection, infection, wound leaks, choroidal effusions or choroidal haemorrhage. IOP elevation of >10 mm Hg was not common (table 3) and few individuals had high pressures (figure 4).
In this study, we evaluated the outcomes of AIT and phaco-AIT by degree of angle opening. No statistically significant differences between narrow (SG≤2) and open (SG≥3) angles were found in IOP and number of medications at 12 months. Narrow angles have previously been seen as a relative contraindication to AIT, whereas phaco-AIT has been performed in narrow angles with less concern because removal of the crystalline lens deepens the anterior chamber angle and may resolve angle closure.10–12 Patients in phaco-AIT were on average about a decade older than in AIT and patients in subgroup SG≤2 were older than ones in SG≥3. Visual acuity was worse in AIT SG≤2 compared with SG≥3, reflecting the average age at which cataracts become visually significant.13 ,14 Lens thickness increases with age15 and can lead to a diminished anterior chamber depth16 and even to phacomorphic angle closure in predisposed individuals.17–19
We observed a mean IOP decrease by approximately 40% from about 27 mm Hg in the AIT groups and by approximately 24% from about 21 mm Hg in the phaco-AIT groups. These findings are similar to previous results that reported a higher baseline IOP in the AIT group and are reflective of different indications1 ,7 ,20 that consisted of high IOP in AIT and of a visually significant cataract and also high IOP or desire to reduce dependence on glaucoma medications in phaco-AIT. Twelve-month pressures and medication reduction were not significantly different, suggesting that AIT-mediated IOP reduction cannot be predicted as a fraction of preoperative levels and that outflow resistance downstream of the TM was similar in all eyes and additive to episcleral venous pressure.21 ,22
Phacoemulsification in itself has been noted to decrease IOP by 1.5–3 mm Hg,23–25 possibly via decompression or mechanical stretch of the TM and Schlemm's canal26 or a stress response pathway activated by ultrasound and other surgical factors.27 However, after TM ablation, one would not expect an additional IOP reduction via these mechanisms. This argues against cataract surgery significantly contributing to outcomes in phaco-AIT in contrast to other MIGS modalities where phacoemulsification alone was found to be nearly as effective as the combination under study.28
The relative efficacy and safety of AIT is apparent by the individual outcomes data in the scattergrams (figure 4): both AIT and phaco-AIT contain subjects with very high preoperative IOP yet no patient had sustained hypotony or other serious postoperative complications (table 3). Few patients experienced a postoperative IOP elevation as seen in other glaucoma surgeries.29 This was more common in phaco-AIT where viscoelastic was used for lens injection. Our study of AIT and phaco-AIT in glaucoma with narrow angles is not directly comparable with studies of trabeculectomy or tube shunt surgery in chronic angle-closure glaucoma (CACG), in which patients had angle closure of at least 180° and synechiae.30–32 Sihota et al31 described an unusually good success rate above 90% using trabeculectomy and glaucoma drops to achieve an IOP below 21 mm Hg. The rate of complications was high with flat chambers occurring in 40% and decreased vision in 58%. Another trial found that phacotrabeculectomy lowered the IOP only by an additional 1.8 mm Hg compared with phacoemulsification alone and achieved this with 1.2 fewer medications.30 Tube shunts are used less commonly in angle-closure glaucomas without same session lens extraction because of challenges in fitting the shunt into the anterior chamber. Wilson et al33 reported on 46 primary open angle glaucoma and 13 CACG eyes and found that while on average more than one complication occurred per eye, surgical success was nevertheless achieved in 68% of cases.
Our study suggests that AIT can be considered in the relatively large population of patients with narrow angles. It was limited by sample size differences and only 1-year follow-up. The results will enable informed design of randomised controlled trials to analyse outcomes and angle changes after AIT in glaucoma patients regardless of angle degree.
In conclusion, AIT and phaco-AIT significantly reduced IOP and number of medications regardless of degree of angle opening and indications should be expanded to include narrow angles.
We would like to acknowledge Ms Jane Lin for her technical support.
Review history and Supplementary material
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online table
Contributors IIB: data collection, statistics, manuscript writing and review, and surgical assistance. KK: statistics, manuscript writing and review, and surgery. JSS: manuscript review and surgery. NAL: data collection, statistics, manuscript writing and review, and surgery.
Competing interests NAL has served as a trabectome wet lab trainer for Neomedix.
Ethics approval Institutional Review Board.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement All data collected here are contained within the manuscript.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.